Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-103323

Chief Executive Officer sold 40,000 shares at an average $68.53 ($2,741,207)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2025-08-01 Sale 10b5-1 −16,745 $67.81 $1,135,416 2,884,625 I: show line 1 in the form
BELANOFF JOSEPH K Chief Executive Officer 2025-08-01 Sale 10b5-1 −17,809 $68.87 $1,226,486 2,866,816 I: show line 2 in the form
BELANOFF JOSEPH K Chief Executive Officer 2025-08-01 Sale 10b5-1 −5,446 $69.65 $379,305 2,861,370 I: show line 3 in the form
Open-market sales · 40,000 sh · avg $68.53 · $2,741,207
Loading xslF345X05/ownership.xml…